nordefrin has been researched along with Cardiomyopathies in 1 studies
Nordefrin: A norepinephrine derivative used as a vasoconstrictor agent.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nöhammer, C | 1 |
| Brunner, F | 1 |
| Wölkart, G | 1 |
| Staber, PB | 1 |
| Steyrer, E | 1 |
| Gonzalez, FJ | 1 |
| Zechner, R | 1 |
| Hoefler, G | 1 |
1 other study available for nordefrin and Cardiomyopathies
| Article | Year |
|---|---|
Myocardial dysfunction and male mortality in peroxisome proliferator-activated receptor alpha knockout mice overexpressing lipoprotein lipase in muscle.
Topics: Animals; Body Weight; Cardiomyopathies; Dose-Response Relationship, Drug; Female; Humans; In Vitro T | 2003 |